Literature DB >> 12634360

CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection.

Matthew J Trifilo1, Cornelia C Bergmann, William A Kuziel, Thomas E Lane.   

Abstract

Chemokines induce the directional migration of targeted populations of leukocytes during periods of inflammation. Moreover, these molecules also regulate T-cell activation and differentiation following antigenic stimulation. In the present study, the contributions of the CC chemokine ligand 3 (CCL3) to the differentiation and migration of effector T cells in response to viral infection of the central nervous system (CNS) were analyzed. CCL3(-/-) mice infected with mouse hepatitis virus exhibited a significant reduction of virus-specific CD8(+) T cells within the CNS, correlating with delayed viral clearance. Decreased infiltration of CD8(+) T cells into infected CCL3(-/-) mice was associated with enhanced accumulation of primed CD8(+) T cells in cervical lymph nodes. Although virus-specific CD8(+) T cells from CCL3(-/-) mice were CD44(high), they remained CD62L(high) and CD25(low), retained CCR7 expression, and contained limited transcripts of the proinflammatory chemokine receptors CCR5 and CXCR3 compared with virus-specific CD8(+) T cells from CCL3(+/+) mice. Furthermore, the absence of CCL3 impaired the cytokine production and cytolytic activity of CD8(+) T cells. In addition, macrophage accumulation within the CNS was significantly decreased in infected CCL3(-/-) mice, correlating with reduced demyelination. These results suggest that CCL3 not only mediates macrophage chemotaxis but also significantly enhances differentiation of primed CD8(+) T cells into effector cells and their release into circulation, thus potentiating effective migration to the site of infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634360      PMCID: PMC150617          DOI: 10.1128/jvi.77.7.4004-4014.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system.

Authors:  C C Bergmann; J D Altman; D Hinton; S A Stohlman
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

2.  CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression.

Authors:  L J Appleman; A Berezovskaya; I Grass; V A Boussiotis
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

Review 3.  The role of chemokine receptors in primary, effector, and memory immune responses.

Authors:  F Sallusto; C R Mackay; A Lanzavecchia
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 4.  Molecular events mediating T cell activation.

Authors:  A Altman; K M Coggeshall; T Mustelin
Journal:  Adv Immunol       Date:  1990       Impact factor: 3.543

5.  A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination.

Authors:  T E Lane; M T Liu; B P Chen; V C Asensio; R M Samawi; A D Paoletti; I L Campbell; S L Kunkel; H S Fox; M J Buchmeier
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Macrophage inflammatory protein-1 alpha is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts.

Authors:  B Mehrad; T A Moore; T J Standiford
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

7.  Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells.

Authors:  F Sallusto; E Kremmer; B Palermo; A Hoy; P Ponath; S Qin; R Förster; M Lipp; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

8.  Distinct migration patterns of naive and effector CD8 T cells in the spleen: correlation with CCR7 receptor expression and chemokine reactivity.

Authors:  C Potsch; D Vöhringer; H Pircher
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

9.  CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination.

Authors:  G F Wu; A A Dandekar; L Pewe; S Perlman
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

10.  In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.

Authors:  S Gillis; K A Smith
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  47 in total

Review 1.  Innate immunity in the central nervous system.

Authors:  Richard M Ransohoff; Melissa A Brown
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

2.  Type 1 T-cell responses in chlamydial lung infections are associated with local MIP-1alpha response.

Authors:  Naihong Zhang; Zhaoe Wang; Xiaofei Tang; Haiping Wang; Hongzhao Li; Huanjun Huang; Hong Bai; Xi Yang
Journal:  Cell Mol Immunol       Date:  2010-07-12       Impact factor: 11.530

3.  CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis.

Authors:  Timothy W Phares; Stephen A Stohlman; Mihyun Hwang; Booki Min; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

4.  Virus-specific and bystander CD8 T cells recruited during virus-induced encephalomyelitis.

Authors:  Audrey M Chen; Nivedita Khanna; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8+ T Cells.

Authors:  Alba Grifoni; Priscilla Costa-Ramos; John Pham; Yuan Tian; Sandy L Rosales; Grégory Seumois; John Sidney; Aruna D de Silva; Lakshmanane Premkumar; Matthew H Collins; Mars Stone; Phillip J Norris; Claudia M E Romero; Anna Durbin; Michael J Ricciardi; Julie E Ledgerwood; Aravinda M de Silva; Michael Busch; Bjoern Peters; Pandurangan Vijayanand; Eva Harris; Andrew K Falconar; Esper Kallas; Daniela Weiskopf; Alessandro Sette
Journal:  J Immunol       Date:  2018-11-09       Impact factor: 5.422

6.  Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade.

Authors:  Mohammad Rashidian; Martin W LaFleur; Vincent L Verschoor; Anushka Dongre; Yun Zhang; Thao H Nguyen; Stephen Kolifrath; Amir R Aref; Christie J Lau; Cloud P Paweletz; Xia Bu; Gordon J Freeman; M Inmaculada Barrasa; Robert A Weinberg; Arlene H Sharpe; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-02       Impact factor: 11.205

7.  Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease.

Authors:  Pamela A Carpentier; Meghann Teague Getts; Stephen D Miller
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

8.  CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination.

Authors:  Linda N Stiles; Michael T Liu; Joy A C Kane; Thomas E Lane
Journal:  Autoimmunity       Date:  2009-09       Impact factor: 2.815

9.  NKG2D receptor signaling enhances cytolytic activity by virus-specific CD8+ T cells: evidence for a protective role in virus-induced encephalitis.

Authors:  Kevin B Walsh; Lewis L Lanier; Thomas E Lane
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

Review 10.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.